Thermo Fisher Scientific’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center is reporting initial findings of stroke research conducted in collaboration with Massachusetts General Hospital (MGH), Harvard University.
Thermo Fisher Scientific is aiming to introduce mass spectrometry-based workflows and technologies into Japan to advance personalized medicine and healthcare and set up a new Biomarker Research Centre in Tokyo, Japan.
Thermo Fisher Scientific is forming an alliance with Intrinsic Bioprobes (IBI) to co-develop and market a mass spectrometry solution that will enable researchers to perform quantitative, high-throughput, high-resolution protein biomarker assays.
Thermo Fisher Scientific introduces Thermo Scientific MetQuest, which is the company’s software solution that enables laboratories to take full advantage of Thermo Scientific’s Orbitrap mass spectrometry (MS) high-resolution accurate-mass (HRAM) full-scan data to perform quantitative metabolic stability studies and identify putative metabolites in a single injection.
Thermo Fisher Scientific and Professor Bruno Domon, director of the new Luxembourg Clinical Proteomics unit (LCP), are collaborating to develop workflows that overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research.
Thermo Fisher Scientific ′s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center is extending its collaboration with George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM), Johns Hopkins University and Toronto's University Health Network (UHN).
Thermo Fisher Scientific plans to demonstrate the advanced analytical capabilities delivered by combining its award-winning Thermo Scientific Exactive liquid chromatography/mass spectrometry (LC/MS) system with its Thermo Scientific Transcend technology for a complete LC/MS solution.
Thermo Fisher Scientific’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center is collaborating with Expression Pathology, Rockville, Maryland, USA, a leader in tissue proteomic analysis, to accurately measure cancer-related proteins in formalin-fixed paraffin-embedded (FFPE) tissue.
A team of researchers at Children's Hospital Boston identifies a promising biomarker, known as LRG, that they believe will help physicians diagnose acute paediatric appendicitis more accurately and efficiently.
Thermo Fisher Scientific introduces a drug screening and confirmation solution for forensic toxicology based on its Thermo Scientific Exactive benchtop LC/MS (liquid chromatography-mass spectrometry) platform.
Thermo Fisher Scientific’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Centre is collaborating with NextGen Sciences to apply new technologies to NextGen Sciences' biomarkerexpress platform, a suite of biomarker services for developing, validating and applying targeted SRM assays for peptides and proteins in biofluids and tissues.
Thermo Fisher Scientific has released the new Thermo Scientific Exactive, a benchtop liquid chromatography-mass spectrometry (LC-MS) system designed for high-throughput and high-performance screening and compound identification applications, at PITTCON 2009.
Thermo Fisher Scientific has launched MetWorks 1.2, an updated version of its metabolite identification software that is a powerful data-mining tool for small molecules that can be used to search for and identify a variety of metabolites with a high degree of accuracy and confidence.
Thermo Fisher Scientific has begun shipping its Proteome Discoverer software with integrated protein annotation powered by the InforSense Virtual Machine and is the first Thermo Fisher Scientific software that embeds the IVM and marks a major milestone in a long relationship between the two companies.
Thermo Fisher Scientific and Sage-N Research have announced the first proteomics software platform designed specifically for the Enterprise Linux market which is the latest product of their five year collaboration on proteomics analysis.
Ameritox, a leading provider of forensic and specialty toxicology laboratory services, has been using Thermo Fisher Scientific’s liquid chromatography tandem mass spectrometry (LC-MS/MS) solution to improve its throughput efficiency.
Thermo Fisher Scientific and Genedata are integrating Thermo Scientific’s mass spectrometry (MS) instrumentation and Genedata Expressionist to efficiently process and analyse large volumes of high-quality MS data, enabling researchers to process hundreds of gigabytes of data simultaneously.
Thermo Fisher Scientific has introduced Proteome Discoverer, a new proteomics analysis software platform that provides the most comprehensive view of quantitative and qualitative proteomic data available.
The Thermo Scientific LTQ Orbitrap hybrid series of mass spectrometers has been enhanced with the introduction of electron transfer dissociation (ETD) and matrix-assisted laser desorption/ionization (MALDI) capabilities.
Thermo Fisher Scientific’s award-winning LTQ Orbitrap linear ion trap mass spectrometer has been chosen by the Institut de Recherches Cliniques de Montreal (IRCM) for use in a new proteomics research approach that could impact the current understanding of the human proteome.
Researchers in Germany's A&M Labs have validated a method that uses Thermo Scientific high-Field Asymmetric waveform Ion Mobility Spectrometry (FAIMS) technology to remove interferences from a drug analysis.